Eurazeo Stock Outlook and Investment Recommendations

Eurazeo is a French investment firm that has been around since 2001, making it a seasoned player in the industry.

Eurazeo's primary focus is on growth capital investments, with a strong emphasis on supporting entrepreneurs and small to medium-sized enterprises (SMEs) in Europe.

The firm has a diverse portfolio of around 50 companies across various sectors, including consumer goods, retail, and technology.

Eurazeo's investment approach is centered around providing long-term support to its portfolio companies, with a typical investment horizon of 5-7 years.

Eurazeo's financial performance has been impressive, with revenue growing by 24% in 2020 to €1.4 billion. This significant increase is a testament to the company's ability to adapt to changing market conditions.

Eurazeo's net asset value (NAV) per share has been steadily increasing, reaching €23.6 in 2020. This growth is a result of the company's successful investments and portfolio management.

The company's EBITDA margin has also improved, reaching 33% in 2020. This increase in profitability is a key factor in Eurazeo's financial success.

Eurazeo's cash and cash equivalents have been steadily increasing, reaching €1.2 billion in 2020. This strong cash position provides the company with financial flexibility and stability.

The company's debt-to-equity ratio has been decreasing, reaching 0.4 in 2020. This reduction in leverage is a sign of Eurazeo's improving financial health.

As an investor, it's essential to understand the key drivers of Eurazeo's stock performance. Eurazeo's diversified portfolio of investments in various sectors, including technology, consumer goods, and healthcare, has contributed significantly to its growth.

Eurazeo's ability to adapt to changing market trends and capitalize on emerging opportunities has been a major factor in its success. With a strong team of experienced professionals, Eurazeo has been able to navigate the complexities of the global market and make informed investment decisions.

Eurazeo's focus on long-term value creation has allowed the company to deliver consistent returns to its investors. By prioritizing sustainable growth and responsible investing, Eurazeo has established itself as a leader in the private equity industry.

Goldman Sachs has upgraded Eurazeo SE to a "Buy" rating, with a boosted price target.

Eurazeo's share price has risen following Goldman Sachs' upgrade to "Buy".

Berenberg remains a "Buy" on Eurazeo, although it has reduced its target price.

Readers also liked: Buy Gesi Stock

Eurazeo's private debt activity has contributed to its strong H1 results.

The Decaux family has tightened its grip on Eurazeo, the French private equity giant.

Eurazeo's Q3 22 results showed a resilient performance in a challenging environment.

Eurazeo's Q3 23 results were impacted by a weaker fundraising environment.

Here's a summary of the analysts' opinions on Eurazeo SE:

The average divergence of analysts' opinions on Eurazeo SE is +22.73%, indicating a relatively high level of agreement among analysts.

When evaluating the performance of your investments, it's essential to consider their returns compared to the broader market and industry.

In the past 7 days, RF returned -5.0%, while FR Diversified Financial returned -3.9% and the French Market returned 0.2%.

The 1-year return for RF was -2.6%, outperforming the French Diversified Financial industry which returned -4.8%.

EUQ underperformed the German Market which returned 14.4% over the past year.

Here's a summary of the shareholder returns for RF and EUQ:

The French Market outperformed RF with a 1-year return of 0.8%.

Eurazeo stock has several competitors in the private equity and venture capital space.

Eurazeo's main competitors include Ardian, CVC Capital Partners, and KKR.

These competitors have a significant presence in the market, with Ardian managing over €100 billion of assets and KKR managing over $200 billion.

Eurazeo, on the other hand, has a more focused approach, with a strong presence in the European market and a portfolio of over 250 investments.

Eurazeo's main competitors in the private equity industry are Apax Partners, Permira, and CVC Capital Partners. These firms have a similar investment focus and size to Eurazeo.

Apax Partners has a global presence with over $50 billion in assets under management. They have made significant investments in various sectors including technology, healthcare, and consumer goods.

Permira has a strong track record of investing in European companies, with over $30 billion in assets under management. They have a focus on consumer and retail investments.

CVC Capital Partners has a global reach with over $100 billion in assets under management. They have invested in various sectors including financial services, technology, and healthcare.

Let's take a closer look at the key metrics that can give us a better understanding of a company's financial health.

Market capitalization is a significant metric, and in this case, it stands at 5,543.55 million euros.

A company's profitability can be measured by its earnings per share (EPS), but unfortunately, this information is not available for this particular company.

The price-to-book (P/B) ratio is another important metric, and it's currently at 0.71.

This low P/B ratio suggests that the company's stock price is relatively low compared to its book value.

The price-to-earnings (P/E) ratio is also a crucial metric, and it's currently at 2.80, indicating that the stock price is relatively low compared to the company's earnings.

Lastly, the dividend yield is a good indicator of a company's ability to distribute its earnings to shareholders, and it's currently at 3.19%.

If this caught your attention, see: Compared to Growth Stocks Value Stocks' Price-earnings Ratio Is Typically

Eurazeo is a French multinational investment company founded in 1969. Eurazeo has a diverse portfolio of over 30 companies across various sectors.

Eurazeo's largest shareholders include the Bettencourt Meyers family and the Caisse des Dépôts.

Eurazeo's stock is listed on the Euronext Paris stock exchange under the ticker symbol RF.